Skip to main content
. 2022 Mar 18;35(7):627–637. doi: 10.1093/ajh/hpac027

Table 2.

Characteristics of participants taking and not taking antihypertensive medication

Characteristic Antihypertensive medication use
No (n = 1,292) Yes (n = 432)
Age, years 47.2 (11.7) 59.0 (8.4)
Age category, %
 <40 26.4 1.2
 40–59 61.8 56.5
 ≥60 11.8 42.4
Male, % 35.9 28.7
Race/ethnicity, %
 Non-Hispanic White 48.0 9.3
 Non-Hispanic Black 31.6 90.7
 Hispanic 14.8 0.0
 Other 5.7 0.0
Less than high school, % 4.2 13.3
Current smoking, % 9.5 10.0
Alcohol intake, %
 No alcohol 44.1 67.1
 Light or moderate 48.3 28.9
 Heavy 7.7 4.0
Body mass index, kg/m2 27.5 (5.6) 32.8 (6.9)
Total cholesterol, mg/dl 191.2 (37.3) 192.3 (42.2)
HDL cholesterol, mg/dl 58.7 (16.8) 55.4 (17.2)
Diabetes, % 6.2 36.1
Family history of hypertension, % 64.4 91.2
Glucose-lowering medication use, % 3.0 29.6
Lipid-lowering medication use, % 5.8 32.7
History of CVD, % 0.9 12.7
eGFR <60, ml/min/1.73 m2 7.4 8.6
ACR >30, mg/g 4.6 16.6
Systolic blood pressure, mm Hg
 Office 111.4 (9.4) 115.7 (8.8)
 Awake 121.6 (10.6) 125.6 (12.0)
 Asleep 106.5 (11.5) 115.2 (14.6)
 24-Hour 117.1 (10.4) 121.7 (12.0)
Diastolic blood pressure, mm Hg
 Office 70.3 (6.3) 69.2 (6.5)
 Awake 75.9 (7.0) 75.9 (8.8)
 Asleep 62.2 (7.6) 65.9 (9.0)
 24-Hour 71.9 (7.0) 71.8 (6.7)
Office heart rate, beats/min 67.8 (10.8) 68.5 (10.7)

Data are expressed as means (SD) or percentages. Participants in this table had an office systolic blood pressure <130 mm Hg and office diastolic blood pressure <80 mm Hg. Abbreviations: ACC, American College of Cardiology; ACR, urinary albumin-to-creatinine ratio; AHA, American Heart Association; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein.